Metro Urology

Appointments: (651) 999-6899

About Us

David J Streitz, M.D.

Residency University of MInnesota; Minneapolis, MN; General Surgery, Urology
Medical School University of Minnesota; Minneapolis, MN
Undergraduate/Graduate Education Hamline University; St. Paul, MN
Certification American Board of Urology

For Dr. David Streitz, medicine runs in the family. His choice to pursue a career in urology was inspired by the example of his father, who was also a urologist. Dr. Streitz is a medical "native son" of Minnesota, since his undergraduate education, medical school and residency were all earned in the Twin Cities However, his research work took him to such far-flung locations as England and Kenya, and his professional presentations include not only U.S. locations but Scotland as well.?

Dr. Streitz knows that there are no 100% guarantees in the treatment of prostate cancer, but his goal is to provide therapies that are both safe and highly effective for his patients. Cryotherapy fits those two criteria. He says, "Cryo allows broader treatment applications for prostate cancer. It offers the advantage of a short convalescence, it's less irritating than radiation, and it's just as - or more - effective.

Besides his clinical interest in general urology, Dr. Streitz is particularly focused on cancer care and treatment. He has been practicing medicine since 1992, when he began a two-year residency in General Surgery, followed by four years in Urology. Dr. Streitz currently practices with Metro Urology.

Hoo Yin Wong, M.D., F.A.C.S., F.R.C.S.C.

Residency University of Manitoba; Winnipeg, Manitoba, Canada; Surgery, Urology
Medical School University of Manitoba Faculty of Medicine; Winnipeg, Manitoba, Canada
Undergraduate/Graduate Education University of Manitoba; Winnipeg, Manitoba, Canada
Certification Licentiate of the Medical Council of Canada
Royal College of Surgeons of Canada in Urology
American Board of Urology
Certified Clinical Densitometrist by the International Society for Clinical Densitometry

Dr. Wong is a partner with Metro Urology, one of the largest private practice groups in the Midwest. Dr. Wong was born in Hong Kong and raised in Winnipeg, Canada. He is fluent in both English and Cantonese. He obtained his M. D. from the University of Manitoba in 1986 and completed his Urology Residency at the same institution in 1992. Following his residency, he completed a two-year fellowship sub-specializing in endourology/kidney stone disease at Baylor College of Medicine in Houston, Texas. He is Board Certified in both the United States and Canada. His clinical interests include kidney stones, Urologic oncology (cancer), laparoscopic and robotic surgery.

Dr. Wong is also a member of our daVinciŽ surgical team for robotic assisted prostatectomies and treatment of prostate cancer.

Dr. Wong is married and has two sons. His outside interests include golfing and tennis.

Parker M. Eberwein, M.D., F.A.C.S., F.R.C.S.C

Residency University of Western Ontario-1993
Medical School University of Calgary-1988
Undergraduate/Graduate Education Internship: Misericordia Community Hospital-1989
Certification Urology, Royal College of Canada
Clinical Interests Laparoscopic and Robotic Surgery

Parker Eberwein, M.D. joined Metro Urology in May, 2007 with more than 14 years of experience in urologic surgery. Dr. Eberwein earned his medical degree from the University of Calgary and completed his post-graduate training in urologic surgery at the University of Western Ontario. He is board certified in both the United States and Canada. Dr. Eberwein serves as Chair of Urology for Health Partners and is based out of Regions Hospital in St. Paul. Dr. Eberwein has extensive laparoscopic surgical experience and has been instrumental in bringing robotic surgery to Regions hospital. He is dedicated to providing up to date care to his patients using the latest in proven technology. He is also highly experienced in endourology, in which a thin fiberoptic scope is used for diagnostic and surgical purposes, and in cryosurgery for the treatment of urologic cancers.

to top ^